The importance of BRCA1 and BRCA2 genes mutations in breast cancer development

Many factors including genetic, environmental, and acquired are involved in breast cancer development across various societies. Among all of these factors in families with a history of breast cancer throughout several generations, genetics, like predisposing genes to develop this disease, should be considered more. Early detection of mutation carriers in these genes, in turn, can play an important role in its prevention. Because this disease has a high prevalence in half of the global population, female screening of reported mutations in predisposing genes, which have been seen in breast cancer patients, seems necessary. In this review, a number of mutations in two predisposing genes (BRCA1 and BRCA2) that occurred in patients with a family history was investigated. We studied published articles about mutations in genes predisposed to breast cancer between 2000 and 2015. We then summarized and classified reported mutations in these two genes to recommend some exons which have a high potential to mutate. According to previous studies, exons have been reported as most mutated exons presented in this article. Considering the large size and high cost of screening all exons in these two genes in patients with a family history, especially in developing countries, the results of this review article can be beneficial and helpful in the selection of exon to screen for patients with this disease.

[1]  D. West,et al.  A novel de novo BRCA1 mutation in a Chinese woman with early onset breast cancer , 2011, Familial Cancer.

[2]  Seyed Mohsen Mousavi,et al.  Cancer incidence and mortality in Iran. , 2009, Annals of oncology : official journal of the European Society for Medical Oncology.

[3]  L. Cortesi,et al.  A novel deletion of BRCA1 gene that eliminates the ATG initiation codon without affecting the promoter region. , 2009, Clinica chimica acta; international journal of clinical chemistry.

[4]  Valerie Beral,et al.  Breast cancer and hormone-replacement therapy in the Million Women Study , 2003, The Lancet.

[5]  Katri Pylkäs,et al.  Analysis of large deletions in BRCA1, BRCA2 and PALB2 genes in Finnish breast and ovarian cancer families , 2008, BMC Cancer.

[6]  B. Strom,et al.  Breast Cancer Risk and Hormone Receptor Status in Older Women by Parity, Age of First Birth, and Breastfeeding: A Case-Control Study , 2008, Cancer Epidemiology Biomarkers & Prevention.

[7]  K. Phillips.  Immunophenotypic and pathologic differences between BRCA1 and BRCA2 hereditary breast cancers. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  Yuntao Xie,et al.  BRCA1 germline mutations and tumor characteristics in Chinese women with familial or early-onset breast cancer , 2009, Breast Cancer Research and Treatment.

[9]  U. Nöthlings,et al.  Identification of a dietary pattern characterized by high-fat food choices associated with increased risk of breast cancer: the European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study. , 2008, The British journal of nutrition.

[10]  T. Walsh,et al.  Spectrum of mutations in BRCA1, BRCA2, CHEK2, and TP53 in families at high risk of breast cancer. , 2006, JAMA.

[11]  J. Biswas,et al.  Influence of dietary habits, physical activity and affluence factors on breast cancer in East India: a case-control study. , 2009, Asian Pacific journal of cancer prevention : APJCP.

[12]  U. Hamann,et al.  Similar contributions of BRCA1 and BRCA2 germline mutations to early-onset breast cancer in Germany , 2003, European Journal of Human Genetics.

[13]  J. Ferlay,et al.  Global Cancer Statistics, 2002 , 2005, CA: a cancer journal for clinicians.

[14]  Å. Borg,et al.  Family history of breast and ovarian cancers and BRCA1 and BRCA2 mutations in a population-based series of early-onset breast cancer. , 2001, Journal of the National Cancer Institute.

[15]  G. Di,et al.  [Mutational analysis of BRCA1 and BRCA2 genes in early-onset breast cancer patients in Shanghai]. , 2005, Zhonghua yi xue za zhi.

[16]  S. Teo,et al.  BRCA1 and BRCA2 Germline Mutations in Malaysian Women with Early-Onset Breast Cancer without a Family History , 2008, PloS one.

[17]  D. Noh,et al.  Comprehensive mutational analysis of BRCA1/BRCA2 for Korean breast cancer patients: evidence of a founder mutation , 2009, Clinical genetics.

[18]  Giovanni Parmigiani,et al.  Meta-analysis of BRCA1 and BRCA2 penetrance. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[19]  Tom L. Blundell,et al.  Insights into DNA recombination from the structure of a RAD51–BRCA2 complex , 2002, Nature.

[20]  L. Volpi,et al.  Mutation analysis of the BRCA1 gene in Malaysian breast cancer patients. , 2002, Singapore medical journal.

[21]  G. Lüleci,et al.  Genomic Large Rearrangement Screening of BRCA1 and BRCA2 Genes in High-Risk Turkish Breast/Ovarian Cancer Patients by Using Multiplex Ligation-Dependent Probe Amplification Assay , 2011, Cancer investigation.

[22]  C. Adebamowo,et al.  Parity and breastfeeding are protective against breast cancer in Nigerian women , 2008, British Journal of Cancer.

[23]  T. Ozcelik,et al.  Germ line BRCA1 and BRCA2 gene mutations in Turkish breast cancer patients. , 2000, European journal of cancer.

[24]  A. Musolino,et al.  A breast cancer patient from Italy with germline mutations in both the BRCA1 and BRCA2 genes , 2005, Breast Cancer Research and Treatment.

[25]  S. Hodgson,et al.  Low Prevalence of BRCA1 Exon Rearrangements in Familial and Young Sporadic Breast Cancer Patients , 2006, Familial Cancer.

[26]  Norman Boyd,et al.  The Breast Cancer Family Registry: an infrastructure for cooperative multinational, interdisciplinary and translational studies of the genetic epidemiology of breast cancer , 2004, Breast Cancer Research.

[27]  H. Park,et al.  Characteristics and Survival of Breast Cancer Patients with Multiple Synchronous or Metachronous Primary Cancers , 2015, Yonsei medical journal.

[28]  M. C. Leske,et al.  Alcohol, tobacco and breast cancer – collaborative reanalysis of individual data from 53 epidemiological studies, including 58 515 women with breast cancer and 95 067 women without the disease , 2002, British Journal of Cancer.

[29]  Michael J Thun,et al.  Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. , 2003, The New England journal of medicine.

[30]  C. Szabo,et al.  High proportion of recurrent germline mutations in the BRCA1 gene in breast and ovarian cancer patients from the Prague area , 2005, Breast Cancer Research.

[31]  J. Garcia-conde,et al.  Mutational analysis of BRCA1 and BRCA2 in Mediterranean Spanish women with early‐onset breast cancer: Identification of three novel pathogenic mutations , 2003, Human mutation.

[32]  H. Barrera-Saldana,et al.  Clinical follow up of mexican women with early onset of breast cancer and mutations in the BRCA1 and BRCA2 genes. , 2005, Salud publica de Mexico.

[33]  O. Olopade,et al.  Advances in Breast Cancer: Pathways to Personalized Medicine , 2008, Clinical Cancer Research.

[34]  F. Bray,et al.  The changing global patterns of female breast cancer incidence and mortality , 2004, Breast Cancer Research.

[35]  S. Fox,et al.  Contribution of large genomic BRCA1 alterations to early-onset breast cancer selected for family history and tumour morphology: a report from The Breast Cancer Family Registry , 2011, Breast Cancer Research.

[36]  S. Vadaparampil,et al.  BRCA1/2 in high-risk African American women with breast cancer: providing genetic testing through various recruitment strategies. , 2008, Genetic testing.

[37]  E. Ostrander,et al.  Frequency of BRCA1/BRCA2 mutations in a population‐based sample of young breast carcinoma cases , 2000, Cancer.

[38]  Douglas F Easton,et al.  Cancer Incidence in BRCA1 mutation carriers. , 2002, Journal of the National Cancer Institute.

[39]  A. Benider,et al.  BRCA1 and BRCA2 germline mutations in Moroccan breast/ovarian cancer families: novel mutations and unclassified variants. , 2012, Gynecologic oncology.

[40]  D. Yannoukakos,et al.  BRCA2 gene mutations in Greek patients with familial breast cancer , 2002, Human mutation.

[41]  N E Day,et al.  A comprehensive model for familial breast cancer incorporating BRCA1, BRCA2 and other genes , 2002, British Journal of Cancer.

[42]  V. Poole,et al.  Iodide transport and breast cancer. , 2015, The Journal of endocrinology.

[43]  G. Lenoir,et al.  Analysis of breast cancer susceptibility genes BRCA1 and BRCA2 in Thai familial and isolated early‐onset breast and ovarian cancer , 2002, Human mutation.

[44]  M. J. van de Vijver,et al.  The pathology of familial breast cancer: predictive value of immunohistochemical markers estrogen receptor, progesterone receptor, HER-2, and p53 in patients with mutations in BRCA1 and BRCA2. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[45]  P. Pharoah,et al.  BRCA1 and BRCA2 mutations in Russian familial breast cancer , 2002, Human mutation.

[46]  Tom Walsh,et al.  Ten genes for inherited breast cancer. , 2007, Cancer cell.

[47]  L. Esserman,et al.  Genetic testing in an ethnically diverse cohort of high-risk women: a comparative analysis of BRCA1 and BRCA2 mutations in American families of European and African ancestry. , 2005, JAMA.

[48]  T. Rebbeck,et al.  Cancer risk estimates for BRCA1 mutation carriers identified in a risk evaluation program. , 2002, Journal of the National Cancer Institute.

[49]  A. Jemal,et al.  Global cancer statistics , 2011, CA: a cancer journal for clinicians.

[50]  D. Easton,et al.  Risk models for familial ovarian and breast cancer , 2000, Genetic epidemiology.

[51]  W. Han,et al.  BRCA1 and BRCA2 germline mutations in Korean breast cancer patients at high risk of carrying mutations. , 2007, Cancer letters.

[52]  Contribution of BRCA1 germ-line mutations to breast cancer in Greece: a hospital-based study of 987 unselected breast cancer cases , 2009, British Journal of Cancer.

[53]  Ilir Agalliu,et al.  Familial clustering of breast and prostate cancer and risk of postmenopausal breast cancer in the Women's Health Initiative Study , 2015, Cancer.

[54]  D. Saranath,et al.  BRCA1/BRCA2 gene mutations/SNPs and BRCA1 haplotypes in early-onset breast cancer patients of Indian ethnicity , 2012, Medical Oncology.

[55]  H. Senn,et al.  BRCA1/2 mutations in Swiss patients with familial or early-onset breast and ovarian cancer. , 2001, Swiss medical weekly.

[56]  M. Jasin,et al.  BRCA2 is required for homology-directed repair of chromosomal breaks. , 2001, Molecular cell.

[57]  G. Abdulrahman,et al.  Epidemiology of Breast Cancer in Europe and Africa , 2012, Journal of cancer epidemiology.

[58]  R. Eeles.  Future possibilities in the prevention of breast cancer: Intervention strategies in BRCA1 and BRCA2 mutation carriers , 2000, Breast Cancer Research.

[59]  H. Neamatzadeh,et al.  BRCA1 and BRCA2 mutations in Iranian breast cancer patients: A systematic review , 2015, Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences.

[60]  D. Baralle,et al.  Identification of a de novo BRCA1 mutation in a woman with early onset bilateral breast cancer , 2009, Familial Cancer.

[61]  B. Kingham,et al.  BRCA1 E1644X: a deleterious mutation in an African American individual with early onset breast cancer , 2008, Breast Cancer Research and Treatment.

[62]  Qiang Li,et al.  Neogenin expression is inversely associated with breast cancer grade in ex vivo , 2014, World Journal of Surgical Oncology.

[63]  S. Narod,et al.  A low frequency of non‐founder BRCA1 mutations in Ashkenazi Jewish breast–ovarian cancer families , 2002, Human mutation.

[64]  R. Dumitrescu,et al.  Understanding breast cancer risk ‐ where do we stand in 2005? , 2005, Journal of cellular and molecular medicine.

[65]  P. Pharoah,et al.  Prevalence and penetrance of BRCA1 and BRCA2 mutations in a population-based series of breast cancer cases , 2000, British Journal of Cancer.

[66]  K. Wani,et al.  Mutational analysis of the BRCA2 gene in breast carcinoma patients of Kashmiri descent. , 2014, Molecular medicine reports.

[67]  J. Ranstam,et al.  Breast cancer and breastfeeding: collaborative reanalysis of individual data from 47 epidemiological studies in 30 countries, including 50 302 women with breast cancer and 96 973 women without the disease , 2002, The Lancet.

[68]  K. Kyriacou,et al.  Contribution of BRCA1 and BRCA2 germline mutations to the incidence of early‐onset breast cancer in Cyprus , 2007, Clinical genetics.

[69]  D. Parkin.  International variation , 2004, Oncogene.

[70]  R. Sutphen,et al.  Identification of the prevalent BRCA1 and BRCA2 mutations in the female population of Puerto Rico. , 2012, Cancer genetics.

[71]  J.,et al.  The New England Journal of Medicine , 2012 .

[72]  Giske Ursin,et al.  Prevalence and predictors of BRCA1 and BRCA2 mutations in a population-based study of breast cancer in white and black American women ages 35 to 64 years. , 2006, Cancer research.

[73]  G. Ricca,et al.  BRCA1 and BRCA2 genetic test in high risk patients and families: counselling and management. , 2010, Oncology reports.

[74]  S. Merajver,et al.  Factors related to incomplete treatment of breast cancer in Kumasi, Ghana. , 2014, Breast.

[75]  S C West,et al.  Role of BRCA2 in control of the RAD51 recombination and DNA repair protein. , 2001, Molecular cell.